SILVER SPRING, Md., April 2, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA announced that it is revising recommendations in several guidances regarding blood...
from PR Newswire: https://ift.tt/2UYs2i0
No comments:
Post a Comment